To test this hypothesis, the authors compared the levels of Ng, VILIP-1, SNAP-25, and Nfl in the CSF of clinically healthy subjects enrolled at the Knight Alzheimer Disease Research Center at Washington University with the aim of identifying and validating AD biomarkers. This evidence concerns the gene SNAP25 and Alzheimer disease.